The incidence of the "dry eye" syndrome diagnosis in developed countries increases from year to year. It is a reason for continuous scientific search for effective and safe methods for its treatment, for new ophthalmic medications. Because of the registration in the Russian Federation of "Hyloparin-Comod" containing heparin, our chair carried out a study on the efficacy of the medication in treatment of several eye diseases associated with the "dry eye" syndrome.